Publications in the field
This retrospective cohort study shows that consultation with a Pulmonary Embolism Response Team (PERT) significantly reduces 30-day mortality, shortens hospital stays, and decreases in-hospital bleeding complications in high-risk PE patients. The study highlights the importance of rapid identification and specialised management in improving outcomes for high-risk PE.
Patients with high- and intermediate-high-risk pulmonary embolism display clinical and haemodynamic instability requiring rapid intervention. This position paper highlights catheter-directed therapies as part of the therapeutic armamentarium. Continuous multidisciplinary risk stratification is paramount in refining selection criteria to deliver the most effective treatment. Management of unstable patients should prioritise a patient-oriented treatment in which transcatheter therapies play a central role.
Novel big data tools can transform real-time analysis of technology implementation. Ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism results in a lower risk of bleeding than mechanical thrombectomy in real-world experience. Bleeding was assessed through direct laboratory measurement and transfusion records. No differences are demonstrated between length of stay and readmission between mechanical thrombectomy and ultrasound-assisted catheter-directed thrombolysis.
This study uses data from the PERT (Pulmonary Embolism Response Team) Consortium Registry to analyse outcomes in patients with intermediate-risk and high-risk PE. Key findings include higher mortality and major bleeding rates in high-risk PE patients, particularly those with catastrophic PE requiring vasopressor support or experiencing cardiac arrest.
This paper discusses the current landscape of transcatheter therapies for acute PE, including ultrasound-assisted catheter-directed thrombolysis and its efficacy in intermediate-risk PE patients.
Reviews recent risk stratification models, serologic biomarkers, and imaging modalities for detecting right ventricular dysfunction in PE patients. It also evaluates advanced treatment strategies beyond standard anticoagulation.
This scientific document from the European Society of Cardiology provides a comprehensive guide for the follow-up management of patients after an acute PE episode.
Meeting
EXPERT-PE conference 18-19 October 2024 in Mainz
EXPERT-PE 2024 is dedicated to increase knowledge on the multidisciplinary initial and chronic management of acute severe pulmonary embolism.
The scientific programme for the upcoming EXPERT-PE conference covers many aspects of the disease, with an overall focus on a multidisciplinary approach, ranging from diagnosis to interventional, medical and multimodal therapy.
The programme will support delegates in introducing and improving the multidisciplinary management of the PE patient with haemodynamic or respiratory compromise in their hospitals. We welcome abstracts, covering both science as well as clinical experience.
Our goal is to offer a platform for sharing and discussing the latest scientific and clinical developments in severe pulmonary embolism, in an informative and dynamic conference.
The conference is designed for practicing clinicians, who regularly care for patients with acute pulmonary embolism, and we thus welcome (interventional) cardiologists, pulmonologists, intensivists, vascular medicine specialists, haematologists, emergency physicians, angiologists, and (interventional) radiologists.
If you should have any questions, please contact us.
